Rights to Subsequent Technologies. MAS shall have no rights in any subsequent discoveries, inventions, and/or technologies resulting from the development of the Licensed Technology by IllumeSys, any Affiliate of IllumeSys or any Sublicensee.
Appears in 4 contracts
Samples: Technology Transfer Agreement (Ciphergen Biosystems Inc), Technology Transfer Agreement (Ciphergen Biosystems Inc), Technology Transfer Agreement (Ciphergen Biosystems Inc)